Dry eye treatment is a process, not an event

Dry eye disease — for most patients — is a chronic condition with multiple contributing factors. Effective treatment addresses those factors systematically. It's not a single appointment or a single treatment that fixes the problem — it's a structured programme of assessment, in-clinic treatment, and home care that produces progressive improvement over weeks and months.

Patients who understand this go on to do better than those who expect immediate or complete resolution after one session.

What the assessment tells you

Your initial dry eye assessment establishes the full picture — what's driving your symptoms, how severe the underlying disease is, how much gland atrophy is present, and what treatment is most likely to help.

It also sets a baseline. Having objective measurements of your gland structure, tear film stability, and symptom scores before treatment starts means we can track your progress accurately and adjust the plan based on how you respond.

Timeline of improvement

The first few weeks Some patients notice early improvement after their first one or two treatment sessions — particularly in comfort and morning symptoms. Others notice little change initially as the treatment begins working on the underlying disease process.

After completing a course For most patients the clearest improvement comes after completing a full treatment course — typically four sessions — and in the weeks that follow as the cumulative effects develop. Meibomian gland function continues to improve for several weeks after the final session.

Longer term Most patients achieve their best results three to four months after starting treatment. Maintenance sessions sustain this improvement over the long term.

What improvement looks like

Treatment outcomes vary between patients depending on the severity of their disease, the degree of gland atrophy present, and their adherence to the home care routine. Realistic expectations for most patients completing a full treatment course include:

• Meaningful reduction in symptom severity and frequency
• Improved tear film stability
• Better meibomian gland secretion quality
• Reduced need for lubricating drops
• Improved comfort with screen use and in challenging environments
• For contact lens wearers — improved lens tolerance

Complete resolution of all symptoms is possible for some patients, particularly those with less advanced disease. For patients with significant gland atrophy, substantial improvement is the realistic goal — not complete cure.

Your role in the process

In-clinic treatment works best when it's supported by a consistent home care routine. Warm compresses, appropriate lid hygiene, omega-3 supplementation, and sensible management of environmental and lifestyle factors all contribute to outcomes.

Patients who engage with the home care routine alongside their in-clinic treatment consistently achieve better results than those who rely on clinic visits alone. We'll build a practical, sustainable routine with you — not an unrealistic list of things you'll do once and forget.

Honesty is central to how we work

We won't overstate what treatment can achieve for your specific situation. At your assessment we'll give you an honest picture of what's driving your symptoms, what the treatment evidence shows, what's realistic for your level of disease — and what the limits are.

Some patients come to us having been told elsewhere that nothing more can be done. Sometimes that's true. Often it isn't. Either way, we'll tell you clearly where things stand.

📍Openshaw Opticians, Unit 4, 16 Cheapside, Cleckheaton, BD19 5AF 

📞 01274 878214